Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (25 quarters reported)
$286M in Q4 2017 → $6.14M now. Hover for any quarter.
As reported for the quarter ended December 31, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Pliant Therapeutics, Inc. | 100.0% | Unchanged | 339,160 | $6.14M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2023 · filed February 14, 2024
No position changes this quarter.
quarter ended September 30, 2023 · filed November 13, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| DT Decibel Therapeutics, Inc. | Exited | −3,139,685 | −$12.1M | — |
quarter ended June 30, 2023 · filed August 10, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Pliant Therapeutics, Inc. | Trimmed | −1,500,000 | −$27.2M | 33.7% |
| Voyager Therapeutics, Inc. | Exited | −3,185,291 | −$24.6M | — |
quarter ended March 31, 2023 · filed May 12, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines, Inc. | Exited | −1,604,130 | −$38.2M | — |
| Voyager Therapeutics, Inc. | Trimmed | −2,243,642 | −$17.3M | 29.6% |
| Fulcrum Therapeutics, Inc. | Exited | −1,962,202 | −$14.3M | — |
quarter ended December 31, 2022 · filed February 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines, Inc. | Trimmed | −2,000,000 | −$47.6M | 29.9% |
| Pliant Therapeutics, Inc. | Trimmed | −2,000,000 | −$38.7M | 27.9% |
| Fulcrum Therapeutics, Inc. | Trimmed | −2,000,000 | −$14.6M | 11.2% |
| JT Jounce Therapeutics, Inc. | Exited | −1,148,780 | −$2.69M | — |
quarter ended September 30, 2022 · filed November 03, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Pliant Therapeutics, Inc. | Trimmed | −2,000,000 | −$41.8M | 35.0% |
| Revolution Medicines, Inc. | Trimmed | −1,500,000 | −$29.6M | 31.0% |
| Nurix Therapeutics, Inc. | Exited | −1,922,549 | −$24.4M | — |
| Voyager Therapeutics, Inc. | Trimmed | −962,243 | −$5.7M | 14.0% |
quarter ended June 30, 2022 · filed August 12, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines, Inc. | Trimmed | −419,901 | −$8.18M | 40.7% |
quarter ended March 31, 2022 · filed May 10, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Nurix Therapeutics, Inc. | Trimmed | −500,000 | −$7.01M | 7.3% |
Loading...
